Reply to: "NNMT aggravates hepatic steatosis but alleviates liver injury in alcoholic liver disease" and "Two sides of NNMT in alcoholic and non-alcoholic fatty liver development".
作者信息
Song Qing, Wang Jun, Griffiths Alexandra, Song Zhenyuan
机构信息
Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL, USA.
Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL, USA.
出版信息
J Hepatol. 2021 May;74(5):1253-1254. doi: 10.1016/j.jhep.2021.01.034. Epub 2021 Jan 30.
PMID:33529671
Abstract
摘要
相似文献
1
Reply to: "NNMT aggravates hepatic steatosis but alleviates liver injury in alcoholic liver disease" and "Two sides of NNMT in alcoholic and non-alcoholic fatty liver development".回复：“NNMT加重酒精性肝病中的肝脂肪变性但减轻肝损伤”以及“NNMT在酒精性和非酒精性脂肪性肝病发展中的两面性”
J Hepatol. 2021 May;74(5):1253-1254. doi: 10.1016/j.jhep.2021.01.034. Epub 2021 Jan 30.
2
NNMT aggravates hepatic steatosis, but alleviates liver injury in alcoholic liver disease.烟酰胺 N-甲基转移酶（NNMT）会加重肝脂肪变性，但可减轻酒精性肝病中的肝损伤。
J Hepatol. 2021 May;74(5):1248-1250. doi: 10.1016/j.jhep.2020.11.025. Epub 2020 Dec 16.
3
Two sides of NNMT in alcoholic and non-alcoholic fatty liver development.NNMT在酒精性和非酒精性脂肪性肝病发展中的两面性。
J Hepatol. 2021 May;74(5):1250-1253. doi: 10.1016/j.jhep.2020.11.049. Epub 2020 Dec 16.
4
Genetic Variants in nicotinamide-N-methyltransferase (NNMT) gene are related to the stage of non-alcoholic fatty liver disease diagnosed by controlled attenuation parameter (CAP)-fibroscan.烟酰胺 - N - 甲基转移酶（NNMT）基因中的遗传变异与通过受控衰减参数（CAP）- 瞬时弹性成像诊断的非酒精性脂肪性肝病分期相关。
J Gastrointestin Liver Dis. 2018 Sep;27(3):265-272. doi: 10.15403/jgld.2014.1121.273.wsh.
5
ER stress-induced upregulation of NNMT contributes to alcohol-related fatty liver development.内质网应激诱导 NNMT 的上调促进了酒精相关性脂肪肝的发生发展。
J Hepatol. 2020 Oct;73(4):783-793. doi: 10.1016/j.jhep.2020.04.038. Epub 2020 May 7.
6
Mouse liver nicotinamide N-methyltransferase pharmacogenetics: biochemical properties and variation in activity among inbred strains.小鼠肝脏烟酰胺N-甲基转移酶药物遗传学：生化特性及近交系间活性差异
Pharmacogenetics. 1996 Feb;6(1):43-53. doi: 10.1097/00008571-199602000-00003.
7
Thiamethoxam induces nonalcoholic fatty liver disease in mice via methionine metabolism disturb via nicotinamide N-methyltransferase overexpression.噻虫嗪通过烟酰胺 N-甲基转移酶过表达干扰蛋氨酸代谢诱导小鼠非酒精性脂肪肝病。
Chemosphere. 2021 Jun;273:129727. doi: 10.1016/j.chemosphere.2021.129727. Epub 2021 Jan 24.
8
Non-Alcoholic Fatty Liver Disease in HIV Infection.HIV感染中的非酒精性脂肪性肝病
AIDS Rev. 2017 Jan-Mar;19(1):35-46.
9
Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research.实验性非酒精性脂肪性肝病研究中的策略、模型和生物标志物。
Prog Lipid Res. 2015 Jul;59:106-25. doi: 10.1016/j.plipres.2015.05.002. Epub 2015 Jun 11.
10
Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization.烟酰胺N-甲基转移酶通过稳定Sirt1蛋白来调节肝脏营养代谢。
Nat Med. 2015 Aug;21(8):887-94. doi: 10.1038/nm.3882. Epub 2015 Jul 13.
引用本文的文献
1
Nicotinamide N-methyltransferase and liver diseases.烟酰胺N-甲基转移酶与肝脏疾病
Genes Dis. 2022 Apr 20;10(5):1883-1893. doi: 10.1016/j.gendis.2022.03.019. eCollection 2023 Sep.
Zotero 插件